Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Mbio|June 20, 2024
Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidaseKevin E Ramos, Nisreen M A Okba, Jessica Tan, et al.ACS Chemical Biology|August 23, 2025
Design of Hyperglycosylated Zika Virus E Proteins that Focus Antibody Recognition on the Complex E Dimer EpitopeMargarette C Mariano, Matthew Gregory Hvasta, Kimberly A Dowd, et al.Cell Chemical Biology|March 1, 2022
Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivoGeorge I Georgiev, Ryan J Malonis, Ariel S Wirchnianski, et al.Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Probing differences among Aβ oligomers with two triangular trimers derived from AβAdam G Kreutzer, Gretchen Guaglianone, Stan Yoo, et al.Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.Archives of Pathology & Laboratory Medicine|April 6, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays: The Value of Numeric ReportingStefanie K Forest, Erika P Orner, D Yitzchak Goldstein, et al.Cell Host & Microbe|August 2, 2020
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its InhibitionM Eugenia Dieterle, Denise Haslwanter, Robert H Bortz, et al.Plos Pathogens|November 8, 2019
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteinsJose A Quiroz, Ryan J Malonis, Larissa B Thackray, et al.Plos Pathogens|April 11, 2024
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodiesAriel S Wirchnianski, Elisabeth K Nyakatura, Andrew S Herbert, et al.Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.Pageof 9